Yiğit Erdemgil

Dr. Yiğit Erdemgil

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AOAYSEL OZPINAR
AYSEL OZPINAR
FKFahrettin Kelestimur
Fahrettin Kelestimur
YSYildiran Songur
Yildiran Songur
OCOzge Can
Ozge Can
LVLiza Valentin
Liza Valentin
BBBen Blount
Ben Blount
Perchlorate, nitrate, and thiocyanate are competitive inhibitors of the sodium iodide symporter of the thyroid membrane. These inhibitors can decrease iodine uptake by the symporter into the thyroid gland and may disrupt thyroid function. This study assesses iodine status and exposure to iodide uptake inhibitors of non-pregnant and non-lactating adult women living in three different cities in Turkey (Istanbul, Isparta and Kayseri). We measured iodine and iodide uptake inhibitors in 24-hr urines collected from study participants (N = 255). All three study populations were mildly iodine deficient, with median urinary iodine (UI) levels of 77.5 µg/L in Istanbul, 58.8 µg/L in Isparta, and 69.8 µg/L in Kayseri. Perchlorate doses were higher in the study population (median 0.13 µg/kg/day), compared with a reference population (median 0.059 µg/kg/day), but lower than the U.S. EPA reference dose (0.7 µg/kg/day). Urinary thiocyanate levels increased with increasing exposure to tobacco smoke, with non-smokers (268 µg/L) significantly lower than light smokers (1110 µg/L), who were significantly lower than heavy smokers (2410 µg/L). This pilot study provides novel data indicating that study participants were moderately iodine deficient and had higher intakes of the iodide uptake inhibitor perchlorate compared with a reference population. Further investigation is needed to characterize the thyroid impact resulting from iodine deficiency coupled with exposure to iodide uptake inhibitors such as perchlorate, thiocyanate and nitrate.

5 February 2025 in Life
Verified
Journal Article
Open access
PDF file
TKTanil Kocagoz
Tanil Kocagoz
BTBetul Temur
Betul Temur
NÜNihan Ünübol
Nihan Ünübol
MEMerve Elmas
Merve Elmas
ZKZeynep Kanlidere
Zeynep Kanlidere
OCOzge Can
Ozge Can
Antimicrobial peptides (AMPs) are a diverse group of small, naturally occurring molecules that orchestrate the innate immune response of various organisms, from microorganisms to humans. Characterized by their broad-spectrum activity against bacteria, fungi and viruses, AMPs are increasingly recognized for their potential as novel therapeutic agents in the face of rising antibiotic resistance. Here, we present several newly designed AMPs, one of which, DTN6, exerts significant activity against several organisms with MIC values as low as 0.5 µg/mL. The D-TN6 peptide influences both bacteria and yeasts. Scanning electron microscopy and transmission electron microscopy results showed that the bacterial membrane is affected by D-TN6, which is resistant to proteases and is effective against antibiotic-resistant pathogens with hemolytic activity and low toxicity. The D-TN6 peptide is effective in vivo against standard S. aureus strains in wounds. Thus, D-TN6 is a potent antibiotic candidate with a broad spectrum of activity. Overall, AMPs are a promising tool for the development of next-generation antimicrobial agents that could mitigate global health threats posed by multidrug-resistant pathogens.

11 February 2016 in Environmental Monitoring and Assessment
Verified
Journal Article
Closed access
PDF file
YEYiğit Erdemgil
Yiğit Erdemgil
TGTuba Gözet
Tuba Gözet
ÖCÖzge Can
Özge Can
IÜIbrahim Ünsal
Ibrahim Ünsal
AOAYSEL OZPINAR
AYSEL OZPINAR

12 June 2014 in Cancer Biomarkers
Verified
Journal Article
Closed access
PDF file
OCOzge Can
Ozge Can
YEYiğit Erdemgil
Yiğit Erdemgil
ZYZeynep Zulfiye Yildirim
Zeynep Zulfiye Yildirim
KÖKoray Özduman
Koray Özduman
MPM. Necmettin Pamir
M. Necmettin Pamir
AOAYSEL OZPINAR
AYSEL OZPINAR
Background: DR-70 is an immunoassay for fibrin and FDP in plasma and it has been shown useful in detection of over 14 different cancers. This study investigated the validity of the DR-70 test in gliomas as well as meningiomas. Methods: 77 brain tumor

16 April 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MYMerve Çelik Yamacı
Merve Çelik Yamacı
CPCeren Pamukcu
Ceren Pamukcu
YEYiğit Erdemgil
Yiğit Erdemgil
AAAhmet Emin Atik
Ahmet Emin Atik
ZKZeynep Zulfiye YILDIRIM KELES
Zeynep Zulfiye YILDIRIM KELES
OCOzge Can
Ozge Can
Background/Objectives: The stress testing of biotherapeutic products is a critical component of drug development, enabling the assessment of stability, biosimilarity, and degradation pathways. Subjecting biosimilar monoclonal antibodies to controlled stress conditions yields essential insights into their structural and functional integrity, informing formulation optimization and mitigating risks before clinical trials. In this study, biosimilar products were comprehensively characterized and compared with originator products under forced degradation. The aim was to expose the products to different stress conditions such as oxidative, pH, thermal, freeze/thaw, and agitation. The products were then tested at defined time points using validated analytical methods. Methods: This study employed size-exclusion chromatography to detect aggregated forms. Isoelectric focusing characterized protein charge variants (e.g., acidic/basic isoforms) from post-translational modifications, while capillary electrophoresis quantified product-related impurities (aggregates and fragments). In addition, a complement assay was used to determine the efficacy and potency under specific stress conditions. Results: Our findings showed that biosimilar and originator products exhibited similar degradation profiles. The biosimilar monoclonal antibody was found to be analytically similar to the originator product in terms of critical parameters related to efficacy and safety under various stress conditions such as aggregation profile, biological activity, and charge variant distribution. Conclusions: Forced degradation studies facilitated the comprehensive and well-validated characterization of the structure and biological activity of biosimilar monoclonal antibody products.

11 March 2024 in Advances in Sample Preparation
Verified
Journal Article
Open access
YEYiğit Erdemgil
Yiğit Erdemgil
MYMerve Çelik Yamacı
Merve Çelik Yamacı
CPCeren Pamukcu
Ceren Pamukcu
FÜFulya Ünalp
Fulya Ünalp
ZKZeynep Zülfiye Yıldırım Keleş
Zeynep Zülfiye Yıldırım Keleş
MSMuhittin Abdulkadir Serdar
Muhittin Abdulkadir Serdar